Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Jia Ji, n/a
Group Leader CPP China
Janssen Research & Development LLC, China (People's Republic)
Poster(s):
021: Strategic & Quantitative Recommendations on Bioanalytical Cross-Validation Experiment Design from a Clinical Pharmacology Perspective
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
107: Pharmacokinetic & Immunogenicity Results from the China Cohort of the MAJESTEC-1 Study of Teclistamab for Relapsed/refractory Multiple Myeloma
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
